How to use IGF1 LR3 1 mg Peptide Sciences
Insulin-like growth factor is essential for normal body development. In its properties it resembles insulin, which is why it is so called. Peptide that repeats the structure of IGF – IGF1 LR3 1 mg Peptide Sciences. Other similar peptides can be found in the brand line, e.g. IGF-1. But they have a much shorter period of activity. The prefix LR3 means that the drug works in the body longer than standard growth factor. This is due to its effect on the body.
How IGF1 LR3 1 mg Peptide Sciences works: effects of taking it
The drug can be considered anabolic, but it is different from standard steroids. The active substance affects the muscles, as well as other body tissues (ligaments, joints) and some internal organs, in particular the liver.
IGF1 LR3 1 mg Peptide Sciences promotes cell division and growth. It also increases the utilisation of blood glucose, after which the body switches to adipose tissue and begins to break down fat cells. This provides the following effects:
- reduction in body fat;
- increased energy production;
- decrease in blood sugar;
- muscle hypertrophy.
IGF1 LR3 1 mg Peptide Sciences is approximately 3 times more potent than regular insulin-like growth factor. It is recommended for athletes in the drying cycle and for light mass gain classes. It is also used in medicine.
Consequences of taking IGF1 LR3 1 mg Peptide Sciences
The peptide acts directly in the cells, not in the blood. Therefore, it has few side effects. The most common is hypoglycemia. Simply put, it is a drop in blood sugar levels. It is accompanied by dizziness, nausea, and weakness. It is recommended to eat a carbohydrate-rich meal or drink a carbohydrate-containing beverage after the injection to avoid this.
Another problem associated with IGF1 LR3 1 mg Peptide Sciences is muscle soreness during exercise. This is due to active tissue enlargement and increased blood flow and usually resolves after a few injections.
How to take IGF1 LR3 1 mg Peptide Sciences correctly
The prescribed dose is administered intramuscularly or subcutaneously. This can be done daily or several times a week when training. It is recommended to inject one hour before the course or immediately after.
The course of the drug is usually 4 to 6 weeks. During this time, you can achieve noticeable results: swollen and enlarged muscles, reduced body fat.
The dosage is determined individually and depends on the training regime, weight and other body characteristics of the athlete.
List of references
- Le Roith D, Yakar S. Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1. Nat Clin Pract Endocrinol Metab. 2007;3(3):302-310. doi: 10.1038/ncpendmet0420.
- Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J, Boisclair YR, LeRoith D. Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest. 2002;110(6):771-781. doi: 10.1172/JCI0215459.
- Muniyappa R, Iantorno M, Quon MJ. An integrated view of insulin resistance and endothelial dysfunction. Endocrinol Metab Clin North Am. 2008;37(3):685-711, viii. doi: 10.1016/j.ecl.2008.06.002.
- Laron Z. Insulin-like growth factor 1 (IGF-1): a growth hormone. Mol Pathol. 2001;54(5):311-316. doi: 10.1136/mp.54.5.311.
- Clemmons DR. Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis, and cancer. Nat Rev Drug Discov. 2007;6(10):821-833. doi: 10.1038/nrd2356.